Illumina Inc (NASDAQ:ILMN)
CAPS Rating:
The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.
The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.
Recs
Takeover is off the table for now, but the valuation is still too high given the fundamentals.